The stem cell gestalt of Geron Goodbye and the future of ACT - The Niche
Last year one of the biggest events in the stem cell field was biotech Geron punting its embryonic stem cell (ESC) program.Much consternation followed.
Professor Paul Knoepfler, Ph.D.
